Compare Abercrombie & Fitch Co. (ANF) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abercrombie & Fitch Co. vs Becton Dickinson and Co — how do they compare? Abercrombie & Fitch Co. trades at $115.48 (market cap $5.24B), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 9.4× Abercrombie & Fitch Co.'s market cap, and Becton Dickinson and Co pays a 2.32% dividend while Abercrombie & Fitch Co. pays none. Which is the better fit depends on your goals.
| ANF | BDX | |
|---|---|---|
Market Cap | $5.24B | $49.41B |
Sector | Consumer Cyclical | Health |
52-Week High | $129.85 | $185.39 |
52-Week Low | $65.61 | $138.62 |
Enterprise Value | $5.91B | $65.51B |
Dividend Yield | — | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abercrombie & Fitch Co.
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Read more on ANF →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
